eq101
·Code: EQ101
eq101: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Equillium, Inc. (EQ) | Phase 2 |
Clinical Trials (1)
An Open-label, Phase 2 Study to Assess the Safety and Efficacy of EQ101 in Adult Subjects With Moderate to Severe Alopecia Areata
Frequently asked questions
Who is developing eq101?
eq101 is being developed by Equillium, Inc..
How many clinical trials involve eq101?
BioSniper tracks 1 clinical trial involving eq101.
Get deeper analysis on eq101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis